PUBMED FOR HANDHELDS

Journal Abstract Search


332 related items for PubMed ID: 9561485

  • 1. Apoptosis in lupus SLE-N IV and non-lupus mesangiocapillary glomerulonephritis type I MCGN. I. A comparative study.
    Wagrowska-Danilewicz M, Danilewicz M.
    J Nephrol; 1998; 11(1):44-9. PubMed ID: 9561485
    [Abstract] [Full Text] [Related]

  • 2. Renal cell apoptosis in human lupus nephritis: a histological study.
    Faurschou M, Penkowa M, Andersen CB, Starklint H, Jacobsen S.
    Lupus; 2009 Oct; 18(11):994-9. PubMed ID: 19762401
    [Abstract] [Full Text] [Related]

  • 3. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 4. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
    Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.
    Pol J Pathol; 2005 Apr 13; 56(3):115-20. PubMed ID: 16334978
    [Abstract] [Full Text] [Related]

  • 5. The significant role of RANTES and CCR5 in progressive tubulointerstitial lesions in lupus nephropathy.
    Stasikowska O, Danilewicz M, Wagrowska-Danilewicz M.
    Pol J Pathol; 2007 Apr 13; 58(1):35-40. PubMed ID: 17585540
    [Abstract] [Full Text] [Related]

  • 6. Dysregulation of apoptosis: a possible mechanism leading to chronic progressive renal histological changes in lupus nephritis.
    Lu F, Shen W, Zhang X, Guo M, Lin S.
    Chin Med J (Engl); 2000 Dec 13; 113(12):1082-6. PubMed ID: 11776141
    [Abstract] [Full Text] [Related]

  • 7. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E, Choi YJ, Barrios R, Nassar G, Suki WN, Truong LD.
    Hum Pathol; 2001 Oct 13; 32(10):1125-35. PubMed ID: 11679948
    [Abstract] [Full Text] [Related]

  • 8. Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I.
    Danilewicz M, Wagrowska-Danilewicz M.
    Nefrologia; 2001 Oct 13; 21(3):253-9. PubMed ID: 11471306
    [Abstract] [Full Text] [Related]

  • 9. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
    Ferluga D, Jerse M, Vizjak A, Hvala A, Rozman B, Kos-Golja M, Bren AF.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):692-701. PubMed ID: 11020959
    [Abstract] [Full Text] [Related]

  • 10. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D, Williams DG, Taube D, Vilches AR, Turner DR, Cameron JS, Ogg CS.
    Q J Med; 1983 Aug 25; 52(208):471-87. PubMed ID: 6606818
    [Abstract] [Full Text] [Related]

  • 11. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
    Arakawa T, Masaki T, Hirai T, Doi S, Kuratsune M, Arihiro K, Kohno N, Yorioka N.
    Nephrol Dial Transplant; 2008 Nov 25; 23(11):3418-26. PubMed ID: 18556750
    [Abstract] [Full Text] [Related]

  • 12. The glomerular distribution of laminin and fibronectin in glomerulonephritis.
    Nakapoulou I, Stefanaki K, Zeis PM, Papadakis J, Boletis J, Vosnidis G, Davaris P.
    Histol Histopathol; 1993 Jul 25; 8(3):521-6. PubMed ID: 7689370
    [Abstract] [Full Text] [Related]

  • 13. Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis.
    Jeruc J, Jurcić V, Vizjak A, Hvala A, Babic N, Kveder R, Praprotnik S, Ferluga D.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):702-6. PubMed ID: 11020960
    [Abstract] [Full Text] [Related]

  • 14. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
    Couzi L, Merville P, Deminière C, Moreau JF, Combe C, Pellegrin JL, Viallard JF, Blanco P.
    Arthritis Rheum; 2007 Jul 25; 56(7):2362-70. PubMed ID: 17599764
    [Abstract] [Full Text] [Related]

  • 15. A study of apoptosis in human glomerulonephritis as determined by in situ non-radioactive labelling of DNA strand breaks.
    Wagrowska-Danilewicz M, Danilewicz M.
    Acta Histochem; 1997 Aug 25; 99(3):257-66. PubMed ID: 9381909
    [Abstract] [Full Text] [Related]

  • 16. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov 25; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 17. [The characteristics of kidney involvement in a female patient with systemic lupus erythematosus and the antiphospholipid syndrome].
    Kozlovskaia NL, Kabaenkova GS, Varshavskiĭ VA, Shvetsov MIu.
    Klin Med (Mosk); 1995 Nov 25; 73(3):93-6. PubMed ID: 8577127
    [Abstract] [Full Text] [Related]

  • 18. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis.
    Dai C, Liu Z, Zhou H, Li L.
    Chin Med J (Engl); 2001 Aug 25; 114(8):864-8. PubMed ID: 11780369
    [Abstract] [Full Text] [Related]

  • 19. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
    Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T, Fukuda K, Kanai H, Nakashima H, Otsuka T, Hirakata H.
    Arthritis Rheum; 2001 Sep 25; 44(9):2097-106. PubMed ID: 11592372
    [Abstract] [Full Text] [Related]

  • 20. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
    Luzar B, Ferluga D.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):716-21. PubMed ID: 11020963
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.